GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2025ACC: 0001415889-25-022797
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-9.76K
Net shares
Net seller
$130.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.76K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.76K
Price / share
$13.39
Trade value
$130.71K
% of position
2.5%
8/20/2025
384.07K→374.31K
Total
Net shares
−9.76K
Net value
-$130.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2025 | F · Tax Withholding | −9.76K | $13.39 | $130.71K | 2.5% | 384.07K | 374.31K |
| Total | −9.76K | -$130.71K | ||||||
Derivative Transactions0
No derivative transactions reported